You are here

MSC Therapy for Immune and Inflammatory Disease

In a review article published recently in STEM CELLS Translational Medicine, researchers led by Men-Luh Yen (National Taiwan University Hospital & College of Medicine, Taipei) and B. Linju Yen (National Health Research Institutes, Zhunan, Taiwan) provide an update and discuss the outcomes of current mesenchymal stem cell therapy (MSCT) trials for immune and inflammatory disease. Furthermore, Wang et al. summarize innovations and emerging trends in the field.